Alexion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析

MarketLineが発行した調査報告書(SWOT20MY3503)
◆英語タイトル:Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3503
◆発行会社(リサーチ会社):MarketLine
◆発行日:2019年11月
◆ページ数:54
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Alexion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Alexion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Alexion Pharmaceuticals, Inc. (Alexion or ‘the company’) is a biopharmaceutical company involved in the innovation, development and commercialization of life-transforming therapeutic products. The company focuses on the therapeutic areas such as Hematology, Neurology, Nephrology and Metabolic disorders.Its product portfolio comprises Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG); Strensiq (asfotase alfa) for the treatment of patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. The company primarily operates in the US, Europe and Asia-Pacific. It is headquartered in New Haven, Connecticut, the US.

Scope

- Detailed information on Alexion Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Alexion Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Alexion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Alexion Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Alexion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Alexion Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Alexion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Alexion Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Alexion Pharmaceuticals, Inc.: Company Overview
Alexion Pharmaceuticals, Inc.: Overview and Key Facts
Alexion Pharmaceuticals, Inc.: Overview
Alexion Pharmaceuticals, Inc.: Key Facts
Alexion Pharmaceuticals, Inc.: Key Employees
Alexion Pharmaceuticals, Inc.: Key Employee Biographies
Alexion Pharmaceuticals, Inc.: Major Products and Services
Alexion Pharmaceuticals, Inc.: Company History
Alexion Pharmaceuticals, Inc.: Management Statement
Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries
Alexion Pharmaceuticals, Inc.: Key Competitors
Alexion Pharmaceuticals, Inc.: Company Analysis
Alexion Pharmaceuticals, Inc.: Business Description
Alexion Pharmaceuticals, Inc.: SWOT Analysis
Alexion Pharmaceuticals, Inc.: SWOT Overview
Alexion Pharmaceuticals, Inc.: Strengths
Alexion Pharmaceuticals, Inc.: Weaknesses
Alexion Pharmaceuticals, Inc.: Opportunities
Alexion Pharmaceuticals, Inc.: Threats
Alexion Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Alexion Pharmaceuticals, Inc.: Financial Deals Overview
Alexion Pharmaceuticals, Inc.: Targets and Partners
Alexion Pharmaceuticals, Inc.: Top Deals 2015 – 2019YTD*
Alexion Pharmaceuticals, Inc.: Advisors
Alexion Pharmaceuticals, Inc.: Top Legal Advisors
Alexion Pharmaceuticals, Inc.: Top Financial Advisors
Alexion Pharmaceuticals, Inc.: Mergers and Acquisitions
Alexion Pharmaceuticals, Inc.: Partnership
Alexion Pharmaceuticals, Inc.: Divestments
Alexion Pharmaceuticals, Inc.: Recent Developments
Alexion Pharmaceuticals, Inc.: News and Events Summary
Alexion Pharmaceuticals, Inc.: Contracts
Alexion Pharmaceuticals, Inc.: Corporate Governance
Alexion Pharmaceuticals, Inc.: Financial Deals
Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals
Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events
Alexion Pharmaceuticals, Inc.: Research & Development
Alexion Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Alexion Pharmaceuticals, Inc.: Key Facts
Table 2: Alexion Pharmaceuticals, Inc.: Key Employees
Table 3: Alexion Pharmaceuticals, Inc.: Company History
Table 4: Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Alexion Pharmaceuticals, Inc.: Key Competitors
Table 6: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Alexion Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Alexion Pharmaceuticals, Inc.: Targets and Partners
Table 10: Alexion Pharmaceuticals, Inc.: Top Deals 2015 - 2019YTD*
Table 11: Alexion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Alexion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Alexion Pharmaceuticals, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: Alexion Pharmaceuticals, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: Alexion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 16: Alexion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 17: Alexion Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 18: Alexion Pharmaceuticals, Inc.: News and Events Summary
Table 19: Alexion Pharmaceuticals, Inc.: Contracts
Table 20: Alexion Pharmaceuticals, Inc.: Corporate Governance
Table 21: Alexion Pharmaceuticals, Inc.: Financial Deals
Table 22: Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals
Table 23: Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 24: Alexion Pharmaceuticals, Inc.: Research & Development
Table 25: Alexion Pharmaceuticals, Inc.: Strategy and Operations

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Alexion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析(Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆